MedCity News February 2, 2025
The DEA recently released three rules regarding the remote prescribing of controlled substances. However, many telehealth advocates argue that two of these rules hinder access to care.
For about half a decade now, Americans have had the ability to receive controlled substances via telehealth because requirements were relaxed during the Covid-19 pandemic. This has greatly expanded access particularly for those in remote areas.
These flexibilities are currently set to expire at the end of 2025. In the final days of the Biden administration, the Drug Enforcement Administration released three new rules relating to telemedicine that aim to keep some of these flexibilities permanent while also implementing new safeguards to promote patient safety.
“DEA’s goal is to provide telehealth access...
Today's Sponsors
Today's Sponsor